Therapeutic management of inflammatory bowel disease in real-life practice in the current era of anti-TNF agents: analysis of the French administrative health databases 2009-2014-Reference-Cited by-同舟云学术

Therapeutic management of inflammatory bowel disease in real-life practice in the current era of anti-TNF agents: analysis of the French administrative health databases 2009-2014

Published:2016-10-26 Issue:1 Volume:45 Page:37-49
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Kirchgesner J.¹²,Lemaitre M.¹,Rudnichi A.¹,Racine A.³,Zureik M.¹,Carbonnel F.³,Dray-Spira R.¹

Affiliation:

1. Department of Epidemiology of Health Products; French National Agency for Medicines and Health Products Safety; Saint-Denis France

2. UMR-S 1136; INSERM & UPMC Univ Paris 06; Paris France

3. Université Paris-Sud; Assistance Publique-Hôpitaux de Paris and Gastroenterology Unit; Hôpitaux Universitaires Paris Sud; Le Kremlin Bicêtre France

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13835/fullpdf

Reference38 articles.

1. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management;Dignass;J Crohns Colitis,2010

2. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: current management;Dignass;J Crohns Colitis,2012

3. Guidelines for the management of inflammatory bowel disease in adults;Mowat;Gut,2011

4. Infliximab, azathioprine, or combination therapy for Crohn's disease;Colombel;N Engl J Med,2010

5. Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis;Panaccione;Gastroenterology,2014

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor Necrosis Factor Inhibitors in Inflammatory Bowel Disease and Risk of Immune Mediated Inflammatory Diseases;Clinical Gastroenterology and Hepatology;2024-01

2. Lack of Benefit for Early Escalation to Advanced Therapies in Ulcerative Colitis: Critical Appraisal of Current Evidence;Journal of Crohn's and Colitis;2023-06-22

3. Long‐term disease course, cost and prognosis of inflammatory bowel disease: epidemiological studies of a European and a Danish inception cohort;APMIS;2023-06

4. Etrasimod for ulcerative colitis: evaluating phase III results;Nature Reviews Gastroenterology & Hepatology;2023-05-23

5. Comparative efficacy and safety of combination therapy with infliximab for Crohn’s disease: a systematic review and network meta-analysis;International Journal of Colorectal Disease;2023-03-27